HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Makeup market trends

This article was originally published in The Rose Sheet

Executive Summary

The natural and anti-aging markets have boomed in the past couple of years as consumers seek fountain of youth, market research firm Mintel announces May 29. From 2001 to 2006, total makeup sales grew handsomely, reaching $6 bil. in food, drug and mass. About 40% of survey respondents reported using makeup with anti-aging ingredients. Anti-aging items experienced $39 mil. in growth from 2004 to 2006, with Maybelline, L'Oréal and Revlon nearly tripling their sales in the category - from $22 mil. to $61 mil. - during that period. More than 40% of consumer respondents said they prefer makeup with all-natural ingredients, and more than 200 makeup items launched in the natural products category in 2007, firm adds...

You may also be interested in...



Dr Reddy’s Knocked Back On Rituximab In US

Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.

Sandoz And Samsung Celebrate Stelara Rival’s EU Approval

Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.

Second EU MDR Notified Body Designated In France

Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014752

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel